Analyzing the Parkinson's disease clinical trial pipeline to facilitate patient collaboration in research.
For greater clarity into the types of PD trials underway, the set of active trials (currently ~500 interventional) can be segmented into portfolios based on various trial characteristics (e.g., disease-modifying, symptomatic, biomarker). The resulting portfolios can then be accessed via direct links to ClinicalTrials.gov, which has filter, search and download features that can be used to further drill-down into the trial data. A portfolio would technically be constructed as a set of trial ID's (NCT#'s), in the same way that a stock portfolio can be represented as set of stock id#'s.
Trial subportfolios can also be created for further granularity (gene therapy, stem cell therapy, repurposed compounds, etc.) A given trial could appear in more than one portfolio/subportfolio.
Select Country, State (U.S. only), City, and Distance.
Sample filters available on ClinicalTrials.gov:
Studies with no phase specified may include evaluations of interventions such as exercise, physical therapy, speech therapy, dietary supplements and more.
* 30 trials are combined Phase 1/Phase 2 OR combined Phase 2/3.
(page under development)